Common pathophysiologic mechanisms in migraine and epilepsy

Archives of Neurology

Volumn 65, Issue 6, 2008, Pages 709-714

  Rogawski, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DIAZEPAM; DIZOCILPINE; GABAPENTIN; GLUTAMIC ACID; IONOTROPIC RECEPTOR ANTAGONIST; KETAMINE; MEMANTINE; PHENYTOIN; TEZAMPANEL; TOPIRAMATE; VALPROIC ACID;

CHANNELOPATHY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; EPILEPSY; FAMILIAL HEMIPLEGIC MIGRAINE; GENE MUTATION; HUMAN; MIGRAINE; MOLECULAR MECHANICS; NEOCORTEX; NERVE EXCITABILITY; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEIZURE; SPREADING CORTICAL DEPRESSION;

BRAIN; CHANNELOPATHIES; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; MIGRAINE DISORDERS;

EID: 45149125845     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.6.709     Document Type: Review

References (43)

1. Wolff HG. Headache and Other Head Pain. 2nd ed. New York, NY: Oxford University Press; 1963.
2. Olesen J, Friberg L, Olesen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol. 1990;28(6):791-798.
3. Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev. 2001;81(3):1065-1096.
4. Leão AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944;7(6):359-390.
5. Lauritzen M. Cortical spreading depression in migraine. Cephalalgia. 2001;21(7):757-760.
6. Milner PM. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. Electroencephalogr Clin Neurophysiol. 1958;10(4):705.
7. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9(4):344-352.
8. Hadjikhani N, Sanchez del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98(8):4687-4692.
9. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002;8(2):136-142.
10. Grafstein B. Mechanism of spreading cortical depression. J Neurophysiol. 1956;19(2):154-171.
11. Strong AJ. Dr. Bernice Grafstein's paper on the mechanism of spreading depression. J Neurophysiol. 2005;94(1):5-7.
12. Herreras O. Electrical prodromals of spreading depression void Grafstein's potassium hypothesis. J Neurophysiol. 2005;94(5):3656-3657.
13. Larrosa B, Pastor J, Lopez-Aguado L, Herreras O. A role for glutamate and glia in the fast network oscillations preceding spreading depression. Neuroscience. 2006;141(2):1057-1068.
14. Tian GF, Azmi H, Takano T, et al. An astrocytic basis of epilepsy. Nat Med. 2005;11(9):973-981.
15. Basarsky TA, Duffy SN, Andrew RD, MacVicar BA. Imaging spreading depression and associated intracellular calcium waves in brain slices. J Neurosci. 1998;18(18):7189-7199.
16. Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW. Visual cortex excitability in migraine with and without aura. Headache. 2001;41(6):565-572.
17. Ptácek LJ. The place of migraine as a channelopathy. Curr Opin Neurol. 1998;11 (3):217-226.
18. Yu FH, Mantegazza M, Westenbroek RE, et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci. 2006;9(9):1142-1149.
19. Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol. 2005;18(3):305-310.
20. Ottman R, Lipton RB. Is the comorbidity of epilepsy and migraine due to a shared genetic susceptibility? Neurology. 1996;47(4):918-924.
21. 2+ channel gene CACNL1A4. Cell. 1996;87(3):543-552.
22. V2.1 current density in neurons. Proc Natl Acad Sci U S A. 2002;99(20):13284-13289.
23. 1a calcium channel gene CACNA1A and idiopathic generalized epilepsy. Neurology. 2001;56(9):1245-1246.
24. 2+ channel α1A subunit gene and exhibits absence seizures. Brain Res. 2007;1133(1):168-177.
25. + pump α2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33(2):192-196.
26. +-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol. 2003;54(3):360-366.
27. De Vries B, Haan J, Frants RR, Van den Maagdenberg AM, Ferrari MD. Genetic biomarkers for migraine. Headache. 2006;46(7):1059-1068.
28. Koenderink JB, Zifarelli G, Qiu LY, et al. Na,K-ATPase mutations in familial hemiplegic migraine lead to functional inactivation. Biochim Biophys Acta. 2005;1669 (1):61-68.
29. Pedley TA, Zuckermann EC, Glaser GH. Epileptogenic effects of localized ventricular perfusion of ouabain on dorsal hippocampus. Exp Neurol. 1969;25 (2):207-219.
30. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005; 366(9483):371-377.
31. Bai ZT, Zhao R, Zhang XY, Chen J, Liu T, Ji YH. The epileptic seizures induced by BmK I, a modulator of sodium channels. Exp Neurol. 2006;197(1):167-176.
32. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004;5(7):553-564.
33. Van Harreveld A. Compounds in brain extracts causing spreading depression of cerebral cortical activity and contraction of crustacean muscle. J Neurochem. 1959;3(4):300-315.
34. Van Harreveld A, Fifková E. Mechanisms involved in spreading depression. J Neurobiol. 1973;4(4):375-387.
35. Marrannes R, Willems R, De Prins E, Wauquier A. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 1988;457(2):226-240.
36. Nellga° rd B, Weiloch T. NMDA-receptor blockers but not NBQX, an AMPA-receptor antagonist, inhibit spreading depression in the rat brain. Acta Physiol Scand. 1992;146(4):497-503.
37. Kaube H, Herzog J, Kaufer T, Dichgans M, Diener HC. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology. 2000;55(1):139-141.
38. Rogawski MA. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents. Amino Acids. 2000;19(1):133-149.
39. Peeters M, Gunthorpe MJ, Strijbos PJ, Goldsmith P, Upton N, James MF. Effects of pan- and subtype-selective NMDA receptor antagonists on cortical spreading depression in the rat. J Pharmacol Exp Ther. 2007;321(2):564-572.
40. Charles A, Flippen C, Romero Reyes M, Brennan KC. Memantine for prevention of migraine: a retrospective study of 60 cases. J Headache Pain. 2007;8(4):248-250.
41. K5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo. J Pharmacol Exp Ther. 2006;318(2):772-781.
42. Sang CN, Ramadan NM, Wallihan RG, et al. LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia. 2004;24(7):596-602.
43. Gryder DS, Rogawski MA. Selective antagonism of GluR5 kainate receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci. 2003;23(18):7069-7074.